stockrowOpus Genetics, Inc. (IRD) vs Surrozen, Inc. (SRZN)
- Opus Genetics, Inc. IRD 4.17 +3.99%
- Surrozen, Inc. SRZN 31.15 +7.41%
Opus Genetics, Inc. and Surrozen, Inc. are both Biotechnology companies. Opus Genetics, Inc. and Surrozen, Inc. are of similar size ($340.9M and $333.2M). Surrozen, Inc. grew revenue faster over the last twelve months: −8.79% against −36.1%. Opus Genetics, Inc. has the higher net margin (−1,091.8% vs −2,887.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Opus Genetics, Inc. leads on 7 and Surrozen, Inc. on 7.
Valuation
Profitability
| Metric | IRD | SRZN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | (513.47%) | (385.28%) | 0.00% |
| Net margin | (1,091.82%) | (2,887.07%) | 0.00% |
| Free cash flow margin | (412.61%) | (303.92%) | 0.00% |
| Return on equity | (4,796.52%) | 387.44% | (51.96%) |
| Return on assets | (163.50%) | (304.47%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack